Joseph D. Khoury, MD is the Stokes-Shackleford Professor and Chair, Department of Pathology and Microbiology, University of Nebraska Medical Center.
In a dynamic presentation at the recent event, Joseph D. Khoury, MD delved into the intricate realm of Acute Myeloid Leukemia (AML), shedding light on genetic advancements, diagnostic nuances, and promising targeted therapies. The engaging discourse began with gratitude for the invitation and San Diego’s delightful weather. Coming from varied backgrounds like Houston, Texas, and even Nebraska, the speaker emphasized their unique vantage point straddling different locales.
The talk swiftly navigated through key concepts and an overarching view of AML classification. The speaker highlighted three cardinal categories of myeloid neoplasms: Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN), and Acute Myeloid Leukemia. Genetic factors were underscored as pivotal triggers for these conditions, with a growing understanding of their intricate interplay over the past decade.